Back to Journals » Research and Reports in Urology » Volume 11

Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia

Authors Da Silva MHA, De Souza DB

Received 11 October 2018

Accepted for publication 7 December 2018

Published 7 January 2019 Volume 2019:11 Pages 1—8

DOI https://doi.org/10.2147/RRU.S155609

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 3

Editor who approved publication: Dr Jan Colli



Marcello Henrique Araujo Da Silva, Diogo Benchimol De Souza

Urogenital Research Unit, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil

Abstract: Benign prostatic hyperplasia (BPH) is a pathology that affects 50% of men over 50 years of age and 90% of men develop BPH in their eighth decade of life. In 2018, more than 1 billion men will be affected by this disease worldwide. However, the progression of BPH is highly complex and has been debated and studied for approximately four decades. Recent studies indicate that BPH can originate from the alteration of different hormone synthesis pathways, and that it is also linked to the function of hormone receptors. There is a close relationship between the progression of BPH and sexual hormones, such as progesterone, testosterone, dihydrotestosterone, and estrogen. The focus of this study was to characterize the interactions of these hormones and investigate the direct or indirect role of each sex hormone receptor in the progression of BPH. Although several studies have described the effects of these hormones on BPH, no conclusions have been drawn regarding their role in disease progression. Here, we present a literature review on the sexual receptors possibly involved in the progression of BPH.

Keywords: benign prostatic hyperplasia, testosterone, progesterone, estrogen, dihydrotestosterone

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]